Baxter (NYSE:BAX) said today that it named Boston Scientific (NYSE:BSX) CEO Mike Mahoney to its board of directors. Mahoney, who engineered a significant turnaround at Boston Scientific, was tapped to serve on Baxter’s governance and compensation committees. “Mike’s significant knowledge of the global medical products business and his track record of leadership will make a significant contribution […]
WaveTec Vision
WaveTec Vision names lead funder in latest $11M raise
Southern California-based WaveTec Vision looked to Northern-California investor Foresite Capital to lead an expansion of its D2 funding round, which has so far pulled in $11 million.
The cataract surgery device maker said all its prior investors also chipped in to the pot, and that the funds will go to launch of the VerifEye surgical monitoring system. The company expanded the funding round that began back in January to meet its goal of $18 million.
Vision: WaveTec raises $11M for cataract surgery tech
California-based vision systems maker WaveTec Vision is more than halfway through an $18 million equity funding round with $11 million raised so far, according to an amended report filed with the SEC this week.
The funding round began January 2, 2013, and has drawn 10 unnamed investors so far, the company reported.
BD to deal labware biz to Corning for $730M | Wall Street Beat
Becton Dickinson & Co. (NYSE:BDX) said it agreed to sell its BD Biosciences – Discovery Labware unit to Corning Inc. (NYSE:GLW) for about $730 million in cash.
Quintiles aims to restructure debt with $2 billion in credit | Funding roundup
Quintiles is resuming its plans to raise more than $2 billion in bank financing.
The Durham, N.C.-based, contract research organization is planning to enter into a new $2.2 billion credit facility, with proceeds from the borrowed funding being used to refinance $1.7 billion in existing debt, including an offer to buy $525 million of 9.5 percent outstanding senior notes that are due in 2014.
